Promising Results Highlight the Efficacy and Safety of ARCT-154: The World's First Approved Self-Amplifying mRNA COVID-19 Vaccine
CSIMarket.com is pleased to present groundbreaking research published in Nature Communications, which sheds light on the safety, immunogenicity, and efficacy of ARCT-154. This innovative vaccine, developed by CSL and Ar...
May 20, 2024
• Major Pharmaceutical Preparations Industry
Business Update
Nasdaq
